Health

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing April 06,…

2 months ago

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

April 06, 2026 10:53 ET  | Source: Celldex Therapeutics, Inc. HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics,…

2 months ago

Sienna Senior Living recognized by The Globe and Mails Women Lead Here Benchmark

April 06, 2026 10:25 ET  | Source: Sienna Senior Living MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Sienna Senior…

2 months ago

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…

2 months ago

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

April 03, 2026 16:01 ET  | Source: Syndax Pharmaceuticals, Inc. NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals…

2 months ago

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 03, 2026 16:00 ET  | Source: IN8bio, Inc NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the…

2 months ago

MEDVi QUAD Claims Evaluated: Real Online Doctor-Approval ED Medication for Men’s Sexual Performance

Newark, DE, April 04, 2026 (GLOBE NEWSWIRE) -- Affiliate Disclosure: If a purchase is made through links in this content,…

2 months ago

Overcoming Onychomycosis Claims Evaluated: Blue Heron Health News Nail Fungus Treatment Program is On Sale

Boise, ID, April 03, 2026 (GLOBE NEWSWIRE) -- This release is based on information provided by Blue Heron Health News…

2 months ago

Matinas BioPharma Receives Notice of Non-Compliance withNYSE AmericanContinued Listing Standards

BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that…

2 months ago

BienRaz Launches Premium D3 + K2 Formula for Bone Health and Heart Function

NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) -- As research continues to reveal the critical relationship between vitamin D3 and…

2 months ago